These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8233056)

  • 1. Magnesium and ketamine attenuate cognitive dysfunction following experimental brain injury.
    Smith DH; Okiyama K; Gennarelli TA; McIntosh TK
    Neurosci Lett; 1993 Jul; 157(2):211-4. PubMed ID: 8233056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the novel NMDA antagonists CP-98,113, CP-101,581 and CP-101,606 on cognitive function and regional cerebral edema following experimental brain injury in the rat.
    Okiyama K; Smith DH; White WF; Richter K; McIntosh TK
    J Neurotrauma; 1997 Apr; 14(4):211-22. PubMed ID: 9151770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-Injury magnesium treatment prevents traumatic brain injury-induced hippocampal ERK activation, neuronal loss, and cognitive dysfunction in the radial-arm maze test.
    Enomoto T; Osugi T; Satoh H; McIntosh TK; Nabeshima T
    J Neurotrauma; 2005 Jul; 22(7):783-92. PubMed ID: 16004581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the NMDA antagonist CP-98,113 on regional cerebral edema and cardiovascular, cognitive, and neurobehavioral function following experimental brain injury in the rat.
    Okiyama K; Smith DH; White WF; McIntosh TK
    Brain Res; 1998 May; 792(2):291-8. PubMed ID: 9593949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroconvulsive therapy-induced persistent retrograde amnesia: could it be minimised by ketamine or other pharmacological approaches?
    Gregory-Roberts EM; Naismith SL; Cullen KM; Hickie IB
    J Affect Disord; 2010 Oct; 126(1-2):39-45. PubMed ID: 20060172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with magnesium improves reference memory but not working memory while reducing GFAP expression following traumatic brain injury.
    Hoane MR
    Restor Neurol Neurosci; 2005; 23(2):67-77. PubMed ID: 15990413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential pharmacotherapy with magnesium chloride and basic fibroblast growth factor after fluid percussion brain injury results in less neuromotor efficacy than that achieved with magnesium alone.
    Guluma KZ; Saatman KE; Brown A; Raghupathi R; McIntosh TK
    J Neurotrauma; 1999 Apr; 16(4):311-21. PubMed ID: 10225217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact.
    Kline AE; Massucci JL; Marion DW; Dixon CE
    J Neurotrauma; 2002 Apr; 19(4):415-25. PubMed ID: 11990348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed administration of basic fibroblast growth factor (bFGF) attenuates cognitive dysfunction following parasagittal fluid percussion brain injury in the rat.
    McDermott KL; Raghupathi R; Fernandez SC; Saatman KE; Protter AA; Finklestein SP; Sinson G; Smith DH; McIntosh TK
    J Neurotrauma; 1997 Apr; 14(4):191-200. PubMed ID: 9151768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postinjury treatment with magnesium chloride attenuates cortical damage after traumatic brain injury in rats.
    Bareyre FM; Saatman KE; Raghupathi R; McIntosh TK
    J Neurotrauma; 2000 Nov; 17(11):1029-39. PubMed ID: 11101206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NPS 1506 attenuates cognitive dysfunction and hippocampal neuron death following brain trauma in the rat.
    Leoni MJ; Chen XH; Mueller AL; Cheney J; McIntosh TK; Smith DH
    Exp Neurol; 2000 Dec; 166(2):442-9. PubMed ID: 11085909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of competitive vs noncompetitive blockade of the NMDA channel following traumatic brain injury.
    Golding EM; Vink R
    Mol Chem Neuropathol; 1995; 24(2-3):137-50. PubMed ID: 7632318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sodium channel blocker and glutamate release inhibitor BW1003C87 and magnesium attenuate regional cerebral edema following experimental brain injury in the rat.
    Okiyama K; Smith DH; Gennarelli TA; Simon RP; Leach M; McIntosh TK
    J Neurochem; 1995 Feb; 64(2):802-9. PubMed ID: 7830074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive
    Witkin JM; Mitchell SN; Wafford KA; Carter G; Gilmour G; Li J; Eastwood BJ; Overshiner C; Li X; Rorick-Kehn L; Rasmussen K; Anderson WH; Nikolayev A; Tolstikov VV; Kuo MS; Catlow JT; Li R; Smith SC; Mitch CH; Ornstein PL; Swanson S; Monn JA
    J Pharmacol Exp Ther; 2017 Apr; 361(1):68-86. PubMed ID: 28138040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remacemide hydrochloride reduces cortical lesion volume following brain trauma in the rat.
    Smith DH; Perri BR; Raghupathi R; Saatman KE; McIntosh TK
    Neurosci Lett; 1997 Aug; 231(3):135-8. PubMed ID: 9300640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine affects memory consolidation: differential effects in T-maze and passive avoidance paradigms in mice.
    Wang JH; Fu Y; Wilson FA; Ma YY
    Neuroscience; 2006 Jul; 140(3):993-1002. PubMed ID: 16600517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective cognitive impairments associated with NMDA receptor blockade in humans.
    Rowland LM; Astur RS; Jung RE; Bustillo JR; Lauriello J; Yeo RA
    Neuropsychopharmacology; 2005 Mar; 30(3):633-9. PubMed ID: 15647751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
    Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
    J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylic acid on behavioral and neurochemical outcome following experimental brain injury.
    Smith DH; Okiyama K; Thomas MJ; McIntosh TK
    J Neurosci; 1993 Dec; 13(12):5383-92. PubMed ID: 8254381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of ketamine combined with penehyclidine hydrochloride on the expression of synaptophysin in the brain of neonatal rats].
    Lin L; Zhang LC; Guo YZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jan; 12(1):51-5. PubMed ID: 20113636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.